143 related articles for article (PubMed ID: 36467497)
1. Cuprotosis Patterns Are Associated with Tumor Mutation Burden and Immune Landscape in Lung Adenocarcinoma.
Liu T; Cai L; Hua H; Jiang X; Xu X; Zhang T; Huang W; Qian L; Bai H; Duan J
J Oncol; 2022; 2022():9772208. PubMed ID: 36467497
[TBL] [Abstract][Full Text] [Related]
2. MMR gene patterns evaluation provides novel insights for personalized immunotherapy compared to neoadjuvant chemotherapy in lung adenocarcinama.
Cai L; Hua H; Jiang X; Xu X; Bai H; Qian L; Duan J
BMC Cancer; 2023 Jun; 23(1):514. PubMed ID: 37280528
[TBL] [Abstract][Full Text] [Related]
3. Molecular typing and prognostic model of lung adenocarcinoma based on cuprotosis-related lncRNAs.
Zheng M; Zhou H; Xie J; Zhang H; Shen X; Zhu D
J Thorac Dis; 2022 Dec; 14(12):4828-4845. PubMed ID: 36647499
[TBL] [Abstract][Full Text] [Related]
4. m6A modification patterns are associated with copy number burden and tumor immune landscape in thyroid cancer.
Cai L; Liu T; Hua H; Jiang X; Qian L
BMC Endocr Disord; 2023 Dec; 23(1):271. PubMed ID: 38057752
[TBL] [Abstract][Full Text] [Related]
5. Identification and validation of novel lung adenocarcinoma subtypes and construction of prognostic models: based on cuprotosis-related genes.
Wang G; Wang A; Wang L; Xu G; Hong X; Fang F
BMC Pulm Med; 2023 Feb; 23(1):63. PubMed ID: 36774456
[TBL] [Abstract][Full Text] [Related]
6. Cross-talk of pyroptosis and tumor immune landscape in lung adenocarcinoma.
Wang X; Lin W; Liu T; Xu Z; Wang Z; Cao Z; Feng X; Gao Y; He J
Transl Lung Cancer Res; 2021 Dec; 10(12):4423-4444. PubMed ID: 35070752
[TBL] [Abstract][Full Text] [Related]
7. Integrative analysis revealed that distinct cuprotosis patterns reshaped tumor microenvironment and responses to immunotherapy of colorectal cancer.
Xu X; Ding C; Zhong H; Qin W; Shu D; Yu M; Abuduaini N; Zhang S; Yang X; Feng B
Front Immunol; 2023; 14():1165101. PubMed ID: 37006250
[TBL] [Abstract][Full Text] [Related]
8. Demystifying the landscape of endometrial immune microenvironment in luteal-phase from cuprotosis: Implications for the mechanism and treatment of RPL.
Zhao X; Wang S; Du T; Jiang Y; Zhao Y; Ma Y; Shen D; Shen Y; Ma J
Gene; 2024 Apr; 903():148191. PubMed ID: 38253297
[TBL] [Abstract][Full Text] [Related]
9. Identification of cuprotosis-mediated subtypes, the development of a prognosis model, and influence immune microenvironment in hepatocellular carcinoma.
Xiao J; Liu Z; Wang J; Zhang S; Zhang Y
Front Oncol; 2022; 12():941211. PubMed ID: 36110946
[TBL] [Abstract][Full Text] [Related]
10. CD1B is a Potential Prognostic Biomarker Associated with Tumor Mutation Burden and Promotes Antitumor Immunity in Lung Adenocarcinoma.
Li Z; Feng Y; Li P; Wang S; Liu X; Xia S
Int J Gen Med; 2022; 15():3809-3826. PubMed ID: 35418778
[TBL] [Abstract][Full Text] [Related]
11. Relationships of N6-Methyladenosine-Related Long Non-Coding RNAs With Tumor Immune Microenvironment and Clinical Prognosis in Lung Adenocarcinoma.
Zhao J; Lin X; Zhuang J; He F
Front Genet; 2021; 12():714697. PubMed ID: 34777460
[No Abstract] [Full Text] [Related]
12. Combination of tumor mutation burden and immune infiltrates for the prognosis of lung adenocarcinoma.
Zhao Z; He B; Cai Q; Zhang P; Peng X; Zhang Y; Xie H; Wang X
Int Immunopharmacol; 2021 Sep; 98():107807. PubMed ID: 34175739
[TBL] [Abstract][Full Text] [Related]
13. m
Zhong J; Liu Z; Cai C; Duan X; Deng T; Zeng G
J Immunother Cancer; 2021 Feb; 9(2):. PubMed ID: 33574053
[TBL] [Abstract][Full Text] [Related]
14. m7G-Associated subtypes, tumor microenvironment, and validation of prognostic signature in lung adenocarcinoma.
Wang G; Zhao M; Li J; Li G; Zheng F; Xu G; Hong X
Front Genet; 2022; 13():954840. PubMed ID: 36046251
[No Abstract] [Full Text] [Related]
15. Prognostic value of lncRNAs related to fatty acid metabolism in lung adenocarcinoma and their correlation with tumor microenvironment based on bioinformatics analysis.
Pan YQ; Xiao Y; Long T; Liu C; Gao WH; Sun YY; Liu C; Shi YJ; Li S; Shao AZ
Front Oncol; 2022; 12():1022097. PubMed ID: 36300102
[TBL] [Abstract][Full Text] [Related]
16. A novel senescence-related lncRNA signature that predicts prognosis and the tumor microenvironment in patients with lung adenocarcinoma.
Fang X; Huang E; Xie X; Yang K; Wang S; Huang X; Song M
Front Genet; 2022; 13():951311. PubMed ID: 36406130
[No Abstract] [Full Text] [Related]
17. Comprehensive Analysis and Reinforcement Learning of Hypoxic Genes Based on Four Machine Learning Algorithms for Estimating the Immune Landscape, Clinical Outcomes, and Therapeutic Implications in Patients With Lung Adenocarcinoma.
Sun Z; Zeng Y; Yuan T; Chen X; Wang H; Ma X
Front Immunol; 2022; 13():906889. PubMed ID: 35757722
[TBL] [Abstract][Full Text] [Related]
18. Comprehensive analysis of a novel signature incorporating lipid metabolism and immune-related genes for assessing prognosis and immune landscape in lung adenocarcinoma.
Wang Y; Xu J; Fang Y; Gu J; Zhao F; Tang Y; Xu R; Zhang B; Wu J; Fang Z; Li Y
Front Immunol; 2022; 13():950001. PubMed ID: 36091041
[TBL] [Abstract][Full Text] [Related]
19. Prognostic significance of pyroptosis-related factors in lung adenocarcinoma.
Lin X; Zhou T; Hu S; Yang L; Yang Z; Pang H; Zhou X; Zhong R; Fang X; Yu Z; Hu K
J Thorac Dis; 2022 Mar; 14(3):654-667. PubMed ID: 35399245
[TBL] [Abstract][Full Text] [Related]
20. Analysis of prognostic genes in the tumor microenvironment of lung adenocarcinoma.
Xu ZY; Zhao M; Chen W; Li K; Qin F; Xiang WW; Sun Y; Wei J; Yuan LQ; Li SK; Lin SH
PeerJ; 2020; 8():e9530. PubMed ID: 32775050
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]